Symptoms and diagnosis
Home
Usage examples
Diseases
Therapies
Medicinal plants
Frequent searches
Medical search
Health topics
Healthy weight
Medical dictionary
Health sites
Questions and answers
Advertisement


Intercept Rises After Data Shows Liver Disease Drug Works
... its design for a Phase 3 trial, which is the last step typically needed before approval. The company plans to target the drug first on a rare disease called primary biliary cirrhosis, in which inflammation destroys bile ducts in the liver and leads ...
Bloomberg - Tue, 12 Aug 2014 08:15

Drug to Treat Fatty Liver Disease Found Effective
Newsmax Health - Tue, 12 Aug 2014 09:18

Intercept Pharma (Nasdaq: ICPT) Stock Skyrockets 45% on Liver Disease ...
Money Morning - Tue, 12 Aug 2014 08:58

Intercept Pharma Soars On Liver-Disease Drug Data ICPT
Investor's Business Daily - Tue, 12 Aug 2014 07:48

Intercept Pharmaceuticals shares soar after drugmaker updates on possible ...
Fox Business - Tue, 12 Aug 2014 06:09



New Guideline Addresses Management of Focal Liver Lesions
... noncancerous lesions such as hepatocellular adenomas and biliary cystadenomas have malignant potential. These lesions may not necessarily present with symptoms attributable to the lesion and are frequently not associated with underlying liver disease.
Medscape - Mon, 25 Aug 2014 13:03

Intercept to Present at Upcoming Investor Conferences
The company's lead product candidate, obeticholic acid (OCA), is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR). OCA is being developed for a variety of chronic liver diseases including primary biliary cirrhosis (PBC), ...
MarketWatch - Tue, 26 Aug 2014 05:06

Study outlines risk factors for solid organ cancers after liver transplantation
Risk was reduced for recipients who received tacrolimus, compared with cyclosporine A (0.56), and for patients who had primary biliary cirrhosis/primary sclerosing cholangitis (0.47) or hepatitis C infection (0.21) as the indication for transplantation ...
The Oncology Report - Tue, 26 Aug 2014 12:41

Zumba for Liam
This disease causes the bile ducts to develop abnormally and blocks the flow of bile from the liver to the intestines leading to liver damage, cirrhosis and eventual death. At 9 months, Baby Liam underwent surgery - the Kasai procedure-connecting his ...
Sun.Star - Wed, 27 Aug 2014 11:33



What You Need to Know About Jaundice
... of the skin. However, understanding why jaundice occurs gives people living with liver disease the information they need to better monitor their health. ... One of the liver's functions is to produce and secrete bile into the intestines to help ...
LiverSupport.com - Mon, 11 Aug 2014 08:30



Why Intercept Is Up 324% This Year
Intercept's drug Obeticholic acid (OCA), which will be used to treat primary biliary cirrhosis (PBC), is in Phase III trials. If approved by the US Food and Drug Administration (FDA), the blockbuster drug is expected to be ... eventually lead to death ...
Bidness Etc - Mon, 18 Aug 2014 05:03

East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More
Telaprevir had one of the most successful drug launches in history, but its run was cut short by a wave of new all-oral, interferon-free regimens for the liver disease. Gilead Sciences' sofosbuvir (Sovaldi) is the first of the group, and has already ...
Xconomy - Fri, 15 Aug 2014 06:53


1  2  3  4  5  6  7  8    ->

Last update: September 2014
Statistics


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014
Statistics